Is the expression status of CD133 associated with the pattern and timing of primary glioblastoma recurrence?
The expression of CD133 may be a predictor of the pattern and timing of recurrence of primary glioblastoma.
The hypothesis of a male depressive syndrome needs further research, focusing on the gradual development of (masked) depression by men in mainly non-clinical samples.